687603-66-3

Basic information

• Product Name: 1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-pentanone
• Synonyms: 1-(1,3-BENZODIOXOL-5-YL)-2-(1-PYRROLIDINYL)-1-PENTANONE;1-(3,4-Methylenedioxyphenyl)-2-pyrrolidinylpentan-1-one;Methylenedioxypyrovalerone;1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-pent;(1-(1,3-Benzodioxol-5-yl)-2-pyrrolidin-1-ylpentan-1-one);3,4-Methylenedioxy Pyrovalerone;Methylenedioxypyrovalerone MDPV Skype : honestcooperation
• CAS NO: 687603-66-3
• Molecular Formula: C16H21NO3
• Molecular Weight: 275.34
• Product Categories: Chemical for Research
• Mol File: 687603-66-3.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 415.5 °C at 760 mmHg
• Flash Point: 205.1 °C
• Appearance: white powder
• Density: 1.169
• PKA: 8.41±0.20(Predicted)
• CAS DataBase Reference: 1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-pentanone(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-pentanone(687603-66-3)
• EPA Substance Registry System: 1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-pentanone(687603-66-3)

Safety Data

• Hazardous Substances Data: 687603-66-3(Hazardous Substances Data)

Usage

Chemical Properties

White Powder

Uses

Stimulant Drug

Upstream product

• 24622-62-6 (R/S)-1-((benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one) hydrochloride 
• 123-75-1 pyrrolidine 
• 146721-06-4 (+/-)-(1R*)-1-Bromo-1-(3,4-methylenedioxybenzoyl)butane 
• 63740-98-7 1-(benzo[d]-1,3-dioxol-5-yl)pentan-1-one 
• 5422-01-5 1-(benzo[d][1,3]dioxol-5-yl)pentan-1-ol 
• 120-57-0 piperonal 

Downstream Products

• 24622-62-6 (R/S)-1-((benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one) hydrochloride 

Relevant articles and documents

Chiral resolution and absolute configuration of the enantiomers of the psychoactive designer drug 3,4-methylenedioxypyrovalerone

Illicit rac-MDPV (3,4-methylenedioxypyrovalerone), manufactured in clandestine labs, has become widely abused for its cocaine-like stimulant properties. It has recently been found as one of the toxic materials in the so-called bath salts, producing, among other effects, psychosis and tachycardia in humans when introduced by any of the several routes of administration (e.g., intravenous, oral, etc.). The considerable toxicity of this designer drug probably resides in one of the enantiomers of the racemate. In order to obtain a sufficient amount of the enantiomers of rac-MDPV to determine their activity, we improved the known synthesis of rac-MDPV and found chemical resolving agents, (+)- and (-)-2'-bromotetranilic acid, that gave the MDPV enantiomers in >96% enantiomeric excess as determined by 1H nuclear magnetic resonance and chiral high-performance liquid chromatography. The absolute stereochemistry of these enantiomers was determined by single-crystal X-ray diffraction studies. Chirality 27:287-293, 2015. Published 2015. This article is a U.S. Government work and is in the public domain in the USA.